Clinical Trial Update: Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma

View source ↗

Summary

A clinical trial comparing the combination of bortezomib, bendamustine, and melphalan versus melphalan alone for multiple myeloma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bendamustine (Bendamustine)
• Bortezomib (bortezomib)
• Melphalan (Melphalan)

Snippet

Sponsor: Uppsala University | Conditions: Myeloma Multiple | Status: RECRUITING